JCJi Che

Ji Che

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ji Che has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Dong

    Department of Anesthesiology, Shanghai Cancer Center Fudan University Shanghai China

    3 shared publications
  • Yuanyuan Wu

    Department of Anesthesiology, Shanghai Cancer Center Fudan University Shanghai China

    3 shared publications
  • Jun Zhang

    Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai, China

    2 shared publications
  • Yali Chen

    Department of Anesthesiology, Shanghai Cancer Center Fudan University Shanghai China

    2 shared publications
  • Changsheng Shi

    Department of Anesthesiology, Shanghai Cancer Center Fudan University Shanghai China

    1 shared publication
  • Haichao Zhang

    Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Fudan University Shanghai China

    1 shared publication

Latest Publications

  • Resveratrol Attenuates Neuroinflammation and Myelination Deficits in Repeated Sevoflurane‐Exposed Neonatal Mice

    by Ji Che, Yuanyuan Wu, Jing Dong, Changsheng Shi, Yali Chen, Zhiyong He, Xiang Zhang, Jun Zhang

    Background: It is reported that repeated neonatal exposure to sevoflurane, a widely used volatile anaesthetic in paediatric anaesthesia, impairs cognitive and fine‐motor functions. Resveratrol has potent anti‐inflammatory and antioxidant properties; however, its role in sevoflurane‐induced hypomyelination is not known. Methods: Neonatal C57BL/6J mice were exposed to 3.5% sevoflurane 2 h daily for 3 consecutive days. Resveratrol of 30 mg/kg was administered intraperitoneally 1 h before each exposure. Cognitive and fine‐motor functions were evaluated by the Morris water maze and single‐pellet reaching task, respectively. Myelination and neuroinflammatory responses in the hippocampus and corpus callosum were examined using immunofluorescence and western blot analyses. In vitro primary microglia and oligodendrocyte precursor cells (OPCs) were used to assess microglia‐mediated inflammation on OPC differentiation. Furthermore, a selective Nrf2 inhibitor ML385 was co‐administered to understand the mechanistic role of resveratrol. Results: Repeated neonatal sevoflurane exposure impaired spatial learning/memory and fine‐motor performance, reduced myelin basic protein (MBP) expression and increased pro‐inflammatory marker (iNOS, CD86, IL‐1β and TNF‐α) expression in both hippocampus and corpus callosum. Resveratrol treatment ameliorated these deficits, evidenced by restoring MBP levels and improving behavioural outcomes. Mechanistically, resveratrol activated the Nrf2/HO‐1 pathway, suppressed microglial M1 polarization and normalized the microglial secretome, thereby promoting OPC differentiation, whereas ML385 attenuated these resveratrol's neuroprotective effects. Conclusions: Resveratrol mitigates sevoflurane‐induced OPCs differentiation impairments and hypomyelination via inhibiting microglial activation, which may be mediated by Nrf2/HO‐1 signalling.


  • Myelination Trajectory and Microglial Dynamics Following Repeated Sevoflurane Exposure in Developing Brain

    by Ji Che, Yuanyuan Wu, Jing Dong, Xuliang Jiang, Li Yang, Yali Chen, Jun Zhang

    The myelination is a critical process during brain development. This study aimed to explore the impact of volatile anesthetic sevoflurane on developing myelination and the role of microglial activation in this process. Neonatal C57BL/6J mice were exposed to sevoflurane at their postnatal 6–8 days. Neurobehavioral tests were used to assess fine motor and cognitive functions. Myelination of hippocampus (HC) and corpus callosum (CC), as well as microglial activation, were determined by western blotting and immunostaining. Lipid droplets were assessed by Oil‐Red‐O and Bodipy staining. Further, primary microglia were co‐cultured with oligodendrocyte precursor cell (OPC) to determine the role of microglia in the proliferation and differentiation of OPC. And microglial inhibitor minocycline and CSF1R inhibitor PLX5622 were administered to assess the effects of microglial activation on developing myelination. The results showed that repeated sevoflurane exposure impaired both fine motor and cognitive functions and induced abnormal expressions of myelin‐related proteins myelin basic protein (MBP) and platelet‐derived growth factor α receptor (PDGFR‐α). And accumulations of lipid droplets were found in the microglia of HC and CC after sevoflurane exposure. Further, the spatiotemporal response to repeated sevoflurane exposure in glial cells exhibited an aberrant myelination process and microglial polarization. The conditioned medium from sevoflurane‐treated microglia inhibited the OPC proliferation and differentiation, while minocycline or PLX5622 alleviated sevoflurane‐induced neuroinflammation and hypomyelination. Therefore, repeated sevoflurane exposure negatively affected OPC differentiation and myelination trajectory through hyperactivating microglia in developing brain, leading to motor and cognitive impairments, while microglial inhibition/depletion could protect against sevoflurane‐induced damage on developing myelination.


  • Open Access

    Human umbilical cord mesenchymal stem cell‐derived exosomes attenuate neuroinflammation and oxidative stress through the NRF2/NF‐κB/NLRP3 pathway

    by Ji Che, Hui Wang, Jing Dong, Yuanyuan Wu, Haichao Zhang, Lei Fu, Jun Zhang

    Aims: We investigated whether human umbilical cord mesenchymal stem cell (hUC‐MSC)‐derived exosomes bear therapeutic potential against lipopolysaccharide (LPS)‐induced neuroinflammation.Methods: Exosomes were isolated from hUC‐MSC supernatant by ultra‐high‐speed centrifugation and characterized by transmission electron microscopy and western blotting. Inflammatory responses were induced by LPS in BV‐2 cells, primary microglial cultures, and C57BL/6J mice. H2O2 was also used to induce inflammation and oxidative stress in BV‐2 cells. The effects of hUC‐MSC‐derived exosomes on inflammatory cytokine expression, oxidative stress, and microglia polarization were studied by immunofluorescence and western blotting.Results: Treatment with hUC‐MSC‐derived exosomes significantly decreased the LPS‐ or H2O2‐induced oxidative stress and expression of pro‐inflammatory cytokines (IL‐6 and TNF‐α) in vitro, while promoting an anti‐inflammatory (classical M2) phenotype in an LPS‐treated mouse model. Mechanistically, the exosomes increased the NRF2 levels and inhibited the LPS‐induced NF‐κB p65 phosphorylation and NLRP3 inflammasome activation. In contrast, the reactive oxygen species scavenger NAC and NF‐κB inhibitor BAY 11–7082 also inhibited the LPS‐induced NLRP3 inflammasome activation and switched to the classical M2 phenotype. Treatment with the NRF2 inhibitor ML385 abolished the anti‐inflammatory and anti‐oxidative effects of the exosomes.Conclusion: hUC‐MSC‐derived exosomes ameliorated LPS/H2O2‐induced neuroinflammation and oxidative stress by inhibiting the microglial NRF2/NF‐κB/NLRP3 signaling pathway.